News and Trends 4 May 2023 World’s first RSV vaccine for older adults gets FDA approval …with an acceptable safety profile. The most frequently observed solicited adverse events were injection site pain, fatigue, myalgia, headache, and arthralgia. These were generally mild to moderate and transient. In… May 4, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 13 Nov 2017 World Antibiotic Awareness Week: Here are Biotech’s Top 5 Strategies to Overcome Resistance …developing a medical device, DAV132. It protects the microbiota from broad-spectrum antibiotics, which prevents nasty bacteria like Clostridium difficile from capitalizing on space left behind. https://www.labiotech.eu/antibiotic-resistance-eu-davolterra/ It is great to… November 13, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 31 Oct 2022 Efflux pump inhibitor research may lead way to beating AMR …as penicillin or erythromycin, work by making their way into a bacterial cell. Once there, the antibiotic prevents the cell from working properly by interfering with its molecular machinery. From… October 31, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 23 Jan 2018 Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest? …the sea squirt, which prevents DNA repair, on the market for the treatment of soft tissue sarcoma and ovarian cancer. In addition, Plitidepsin and Lurbinectedin are being investigated in Phase… January 23, 2018 - 10 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2018 Antibody Hitting Tumor Self-Destruct Button Passes Phase I …by tumor cells in cancers such as ovarian and breast cancer. The protein prevents the natural self-destruct mechanism in cells, letting tumor cells multiply unchecked by the immune system. Following… December 12, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 14 Mar 2025 Can GLP-1 agonists help treat addiction? …side effect. As more trials continue to take place testing GLP-1 drugs for the treatment of other indications, including heart failure, sleep apnea, advanced fatty liver disease, and cardiovascular events,… March 14, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Jun 2025 From undruggable to oral therapy: The rise of STAT6 degraders …trial completed in 2025, the drug was administered once daily and found to be well-tolerated, with no serious or severe adverse events and a safety profile similar to placebo. Pharmacodynamic… June 18, 2025 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2016 What do the CAR-T Patient Deaths Mean for the Future of the Field? …syndrome and 15 percent had a neurological or psychiatric event—there were no deaths. This announcement comes as a surprisingly positive turn of events after Novartis raised eyebrows back in September… December 14, 2016 - 7 minutesmins - By Diana Kwon Share WhatsApp Twitter Linkedin Email
News and Trends 20 Feb 2018 This Gene Therapy for Vision Loss is Safe and Effective After Two Years …GS010 is safe and effective for use in patients with LHON. After 96 weeks, there were no unexpected or serious adverse events related to the treatment or procedure. Although the… February 20, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
More News! 13 Nov 2018 French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins …not controllable with approved drugs. By lowering blood pressure, the drug could cut the risk of life-threatening cardiovascular events such as heart attacks and strokes. The drug also showed a… November 13, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 6 Jul 2020 How Immuno-Oncology Contributes to the Fight Against Covid-19 …reflects Cerullo. The ongoing events are also giving us ground to reflect on how interconnected scientific progress is. It is impressive to observe how advancements in one field are contributing… July 6, 2020 - 7 minutesmins - By Maya Chergova Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2022 PerkinElmer’s Horizon Discovery: the lowdown on base editing …the health of the cells by reducing the number of events needed to achieve the final product. This is particularly important for fragile cells such as iPSCs. Is there still… October 17, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email